Role of hyperlipidemia in progressive renal disease: Focus on diabetic nephropathy

This publication has 22 references indexed in Scilit:

• A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR)
  Kidney International, 1998
• Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats
  American Journal of Kidney Diseases, 1998
• Transforming growth factor β1 and renal injury following subtotal nephrectomy in the rat: Role of the renin-angiotensin system
  Kidney International, 1997
• Understanding the nature of renal disease progression
  Kidney International, 1997
• Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats
  Kidney International, 1996
• The effect of macrophage colony-stimulating factor (M-CSF) on the progression of lipid-induced nephrotoxicity in diabetic nephropathy
  Journal of Diabetes and its Complications, 1995
• Relationship of progressively increasing albuminuria to apoprotein(a) and blood pressure in Type 2 (non-insulin-dependent) and Type 1 (insulin-dependent) diabetic patients
  Diabetologia, 1993
• Lovastatin inhibits proliferation of rat mesangial cells.
  Journal of Clinical Investigation, 1993
• A High Cholesterol Diet Ameliorates Renal Tubular Lesions in Diabetic Rats
  Experimental Biology and Medicine, 1990
• Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure.
  Circulation Research, 1988